Proteomic analysis of polypeptides captured from blood during extracorporeal albumin dialysis in patients with cholestasis and resistant pruritus

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Gay, Marina ^a   Pares, Albert ^b   Carrascal, Montserrat ^a   Bosch i Crespo, Pau ^a,b   Gorga, Marina ^a,b   Mas, Antoni ^b   Abian, Joaquin ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; BINDING PROTEIN; FIBRINOGEN; HORMONE PRECURSOR; NEUTROPHIL DEFENSIN 1 PROTEIN; SECRETED LY 6 UPAR RELATED PROTEIN 1; UNCLASSIFIED DRUG; ALPHA DEFENSIN; ARS PROTEIN, HUMAN; DEFENSIN 1; LY ANTIGEN; PANCREAS POLYPEPTIDE; PEPTIDE; SERUM AMYLOID A; UROKINASE;

ALBUMIN DIALYSIS; AMINO ACID SEQUENCE; ANION EXCHANGE; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; LIQUID CHROMATOGRAPHY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PRURITUS; SEQUENCE ANALYSIS; STRUCTURAL PROTEOMICS; TANDEM MASS SPECTROMETRY; THERAPY EFFECT; UNINDEXED SEQUENCE; VALIDATION PROCESS; WESTERN BLOTTING; METHODOLOGY; PROTEOMICS; RENAL REPLACEMENT THERAPY;

ALPHA-DEFENSINS; ANTIGENS, LY; BLOTTING, WESTERN; CHOLESTASIS; HUMANS; PANCREATIC POLYPEPTIDE; PEPTIDES; PROTEOMICS; PRURITUS; RENAL DIALYSIS; SERUM AMYLOID A PROTEIN; TANDEM MASS SPECTROMETRY; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 79960350916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021850     Document Type: Article

References (35)

1. Jalan R, Kapoor D, Steiner C, Williams R, (2001) Mars in decompensated alcoholic liver disease with multi-organ failure. Z Gastroenterol 39: (Suppl. 2): 12.
2. Williams R, (2007) Acute liver failure-practical management. Acta Gastroenterol Belg 70: 210-213.
3. Sen S, Williams R, Jalan R, (2005) Emerging indications for albumin dialysis. Am J Gastroenterol 100: 468-475.
4. Heemann U, Treichel U, Loock J, Philipp T, Gerken G, et al. (2002) Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 36: 949-958.
5. Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, et al. (2006) Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 10: R108.
6. Saliba F, (2006) The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure. Crit Care 10: 118-120.
7. Catalina MV, Barrio J, Anaya F, Salcedo M, Rincón D, et al. (2003) Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver Int 23: 39-43.
8. Parés A, Herrera M, Avilés J, Sanz M, A M, (2010) Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. J Hepatol 53: 307-312.
9. Parés A, Cisneros L, Salmerón JM, Caballería L, Mas A, et al. (2004) Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 99: 1105-1110.
10. Yosipovitch G, Greaves MW, Schmelz M, (2003) Itch. Lancet 361: 690-694.
11. Jones EA, Bergasa NV, (1999) The pruritus of cholestasis. Hepatology 29: 1003-1006.
12. Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, et al. (2003) Itch: scratching more than the surface. QJM 96: 7-26.
13. Kremer AE, Beuers U, Oude-Elferink RP, Pusl T, (2008) Pathogenesis and treatment of pruritus in cholestasis. Drugs 68: 2163-2182.
14. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, et al. (1999) Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 23: 319-330.
15. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, et al. (2001) Extracorporeal detoxification using the Molecular Adsorbent Recirculating System for critically Ill patients withliver failure. J Am Soc Nephrol 12: S75-S82.
16. Auth MK, Kim HS, Beste M, Bonzel KE, Baumann U, et al. (2004) Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. J Pediatr Gastroenterol Nutr 40: 54-59.
17. Gay M, Carrascal M, Gorga M, Parés A, Abian J, (2010) Characterization of peptides and proteins in commercial albumin solutions. Proteomics 10: 172-181.
18. Cohn EJ, Strong LE, Hughes WL, Mulford DJ, Ashworth JN, et al. (1946) Preparation and properties of serum and plasma proteins. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluid. J Am Chem Soc 68: 459-475.
19. Gundry RL, Fu Q, Jelinek CA, Van Eyk JE, Cotter RJ, (2007) Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin Appl 1: 73-88.
20. Lowenthal MS, Mehta AI, Frogale K, Bandle RW, Araujo RP, et al. (2005) Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 51: 1933-1945.
21. Ross P, Huang Y, Marchese J, Williamson B, Parker K, et al. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169.
22. Ziganshin R, Arapidi G, Azarkin I, Zaryadieva E, Alexeev D, et al. (2011) New method for peptide desorption from abundant blood proteins for plasma/serum peptidome analyses by mass spectrometry. J Proteomics 74: 596-606.
23. Zheng X, Baker H, Hancock W, (2006) Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J Chromatogr A 1120: 173-184.
24. Tiss A, Smith C, Menon U, Jacobs I, Timms J, et al. (2010) A well-characterised peak identification list of MALDI MS profile peaks for human blood serum. Proteomics 10: 3388-3392.
25. Choi H, Fermin D, Nesvizhskii A, (2008) Significance analysis of spectral count data in label-free shotgun proteomics. Mol Cell Proteomics 7: 2373-2385.
26. Dennis GJ, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
27. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc 4: 44-57.
28. Snel B, Lehmann G, Bork P, Huynen MA, (2000) STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res 28: 3442-3444.
29. Patzer JFn, (2008) Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure. Artif Organs 37: 499-508.
30. Chimienti F, Hogg RC, Plantard L, Lehmann C, Brakch N, et al. (2003) Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum Mol Genet 12: 3017-3024.
31. Heyer G, Vogelgsang M, Hornstein OP, (1997) Acetylcholine is an inducer of itching in patients with atopic eczema. J Dermatol 24: 621-625.
32. Arredondo J, Chernyavsky AI, Webber RJ, Grando SA, (2005) Biological effects of SLURP-1 on human keratinocytes. J Invest Dermatol 125: 1236-1241.
33. Fischer J, Bouadjar B, Heilig R, Huber M, Lefèvre C, et al. (2001) Mutations in the gene encoding SLURP-1 in Mal de Meleda. Hum Mol Genet 10: 351-355.
34. Chen J, Raymond K, (2005) Treatment Effect of Rifampicin on Cholestasis. The Internet Journal of Pharmacology 3.
35. Carrascal M, Ovelleiro D, Casas V, Gay M, Abian J, (2008) Phosphorylation Analysis of Primary Human T Lymphocytes Using Sequential IMAC and Titanium oxide Enrichment. J Proteome Res 7: 5167-5176.